Israeli hospital to start fourth Covid jab efficacy study

Sheba Medical Center will administer a fourth dose to 150 medical workers who were vaccinated with third doses before August 20.
Image: Hannah Beier/Bloomberg

A leading Israeli hospital has started what it says is the first formal clinical trial examining the safety and efficacy of a fourth dose of coronavirus vaccine.

Sheba Medical Center has begun to administer a fourth dose to 150 medical workers who received third doses before August 20 and currently have a low antibody count, according to a statement from the hospital. The trial is being done in conjunction with Israel’s Health Ministry.

Prime Minister Naftali Bennett announced last week that the government would adopt the recommendation of a panel of experts to inoculate older adults and medical personnel with a fourth dose of Pfizer-BioNTech vaccine in a bid to shore up protection against the fast-spreading omicron variant.

However, a few days later, the Health Ministry said its director-general had not yet decided whether to go ahead with the immunisation drive. Some experts had questioned the wisdom of a fourth shot given the paucity of supporting data.

Initial data regarding safety will be available in a few days, said Professor Gili Regev-Yochay, who is spearheading the trial at Sheba.

© 2021 Bloomberg L.P.

COMMENTS   0

You must be signed in and an Insider Gold subscriber to comment.

SUBSCRIBE NOW SIGN IN

LATEST CURRENCIES  

USD / ZAR
GBP / ZAR
EUR / ZAR
BTC / USD

Subscribe to our mailing list

* indicates required
Moneyweb newsletters

Instrument Details  

You do not have any portfolios, please create one here.
You do not have an alert portfolio, please create one here.
INSIDER SUBSCRIPTION APP VIDEOS RADIO / LISTEN LIVE SHOP OFFERS WEBINARS NEWSLETTERS TRENDING

Follow us: